Page last updated: 2024-11-05

urapidil and Pulmonary Hypertension

urapidil has been researched along with Pulmonary Hypertension in 13 studies

Research Excerpts

ExcerptRelevanceReference
"Urapidil can prevent hypoxic pulmonary hypertension."7.72[Preventive effects of urapidil on hypoxic pulmonary hypertension in rats]. ( Chen, XJ; Cheng, DY; Guan, J; Xia, XQ, 2004)
"Urapidil is a new vasodilator that acts by postsynaptic alpha 1-blockade while inhibiting the aortic pressure baroreceptor reflex and reducing central sympathetic tone."6.66Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine. ( Abrouk, F; Adnot, S; Brun-Buisson, C; Defouilloy, C; Lemaire, F; Piquet, J, 1987)
"Urapidil is known to be an alpha 1-adrenoceptor antagonist and an agonist of central 5HT1A-receptors, and should be considered as a vasodilator."5.29Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. ( Adnot, S; Samoyeau, R; Weitzenblum, E, 1995)
"Urapidil can prevent hypoxic pulmonary hypertension."3.72[Preventive effects of urapidil on hypoxic pulmonary hypertension in rats]. ( Chen, XJ; Cheng, DY; Guan, J; Xia, XQ, 2004)
"Urapidil is a new vasodilator that acts by postsynaptic alpha 1-blockade while inhibiting the aortic pressure baroreceptor reflex and reducing central sympathetic tone."2.66Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine. ( Abrouk, F; Adnot, S; Brun-Buisson, C; Defouilloy, C; Lemaire, F; Piquet, J, 1987)
"Urapidil is known to be an alpha 1-adrenoceptor antagonist and an agonist of central 5HT1A-receptors, and should be considered as a vasodilator."1.29Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. ( Adnot, S; Samoyeau, R; Weitzenblum, E, 1995)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19905 (38.46)18.7374
1990's7 (53.85)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xia, XQ1
Cheng, DY1
Guan, J1
Chen, XJ1
Späh, F2
Kottman, R1
Schmidt, U2
Adnot, S4
Samoyeau, R1
Weitzenblum, E1
Galinier, M1
Rougé, P1
Fourcade, J1
Senard, JM1
Albenque, JP1
Balanescu, S1
Doazan, JP1
Montastruc, JL1
Bounhoure, JP1
Montastruc, P1
Lewczuk, J1
Wrabec, K1
Kottmann, R1
Grosser, KD1
Thieme, G1
M'Buyamba-Kabangu, JR1
Bielen, E2
Staessen, J2
Fagard, R2
Lijnen, P2
Van Hoof, R2
Amery, A2
Andrivet, P1
Piquet, J2
Brun-Buisson, C2
Rauss, A1
Bignon, J1
Lemaire, F3
Defouilloy, C2
Abrouk, F2
Kouzan, S1
Rubin, LJ1

Reviews

2 reviews available for urapidil and Pulmonary Hypertension

ArticleYear
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
    Pneumonologia i alergologia polska, 1991, Volume: 59, Issue:3-4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel B

1991
Urapidil-induced hemodynamic changes in humans.
    The American journal of cardiology, 1989, Aug-15, Volume: 64, Issue:7

    Topics: Acute Disease; Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertens

1989

Trials

3 trials available for urapidil and Pulmonary Hypertension

ArticleYear
Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung disease.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Diltiazem; Femal

1994
The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    The American review of respiratory disease, 1988, Volume: 137, Issue:5

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Carbon Dioxide; Clinical Trials as Topic; Forced Expi

1988
Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    The American review of respiratory disease, 1987, Volume: 135, Issue:2

    Topics: Aged; Blood Pressure; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmo

1987

Other Studies

8 other studies available for urapidil and Pulmonary Hypertension

ArticleYear
[Preventive effects of urapidil on hypoxic pulmonary hypertension in rats].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2004, Volume: 35, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Arterioles; Heart Ventricles; Hypertension, Pulmonary; Hypoxi

2004
Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Blood pressure. Supplement, 1995, Volume: 3

    Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive

1995
Lack of haemodynamic effects of nitric oxide on post-capillary pulmonary hypertension induced by acute sino-aortic denervation.
    British journal of pharmacology, 1997, Volume: 120, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Denervation; Dogs; Enzyme Inhibitors; Hemodynamics; Hypertensi

1997
[Therapy of hypertensive crises. Profile of intravenous Ebrantil].
    Der Anaesthesist, 1994, Volume: 43, Issue:6 Suppl

    Topics: Antihypertensive Agents; Humans; Hypertension; Hypertension, Pulmonary; Injections, Intravenous; Int

1994
Effects of urapidil in patients with mild pulmonary vascular hypertension.
    Drugs, 1990, Volume: 40 Suppl 4

    Topics: Aged; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, In

1990
[Hemodynamic effects of urapidil in men].
    Presse medicale (Paris, France : 1983), 1990, Sep-22, Volume: 19, Issue:30

    Topics: Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary;

1990
Haemodynamic effects of urapidil compared to hydralazine in pulmonary hypertension.
    European journal of respiratory diseases. Supplement, 1986, Volume: 146

    Topics: Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Male; Oxygen; Piperazines

1986
Vasodilators and pulmonary hypertension: where do we go from here?
    The American review of respiratory disease, 1987, Volume: 135, Issue:2

    Topics: Blood Pressure; Humans; Hydralazine; Hypertension, Pulmonary; Piperazines; Pulmonary Circulation; Va

1987